Clinical trial
90% Effective Dose of Tegileridine Combined With Propofol for Inhibiting Laryngeal Mask Airway Insertion Responses in Patients of Different Ages: A Biased-Coin Sequential Allocation Dose-Finding Study
NCT07665151 is registered in ClinicalTrials.gov with Shiyou Wei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 90% Effective Dose of Tegileridine Combined With Propofol for Inhibiting Laryngeal Mask Airway Insertion Responses in Patients of Different Ages: A Biased-Coin Sequential Allocation Dose-Finding Study
- Lead sponsor
- Shiyou Wei
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 25, 2026
- Completion date
- July 21, 2026
- Enrollment
- 109 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
elective surgery requiring laryngeal mask airway general anesthesia